Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UPEXI, INC. Director's Dealing 2025

Nov 19, 2025

33031_dirs_2025-11-18_251fed85-eb13-4411-82e9-7388ad532523.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UPEXI, INC. (UPXI)
CIK: 0001775194
Period of Report: 2025-11-17-05:00

Reporting Person: Salkind Gene (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-11-17-05:00 Common Stock P 100000 $2.65 Acquired 569470 Direct
2025-11-17-05:00 Common Stock P 100000 $2.81 Acquired 168750 Indirect

Footnotes

F1: 100,000 shares were purchased at $2.81 per share on the open market through the Marital Trust GST subject U/W/O Leopold Salkind Gene Salkind, Trustee. These shares are considered indirect ownership of Gene Salkind.